These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 207283)

  • 1. Cyclic nucleotide metabolism in Walker carcinoma cells resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1978 Mar; 27(6):947-52. PubMed ID: 207283
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(16):1831-6. PubMed ID: 9089
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of alkylating agents on adenosine 3',5'-monophosphate metabolism in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(15):1793-7. PubMed ID: 182174
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jul; 24(13-14):1271-6. PubMed ID: 167787
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agents.
    Tisdale MJ
    Biochim Biophys Acta; 1975 Jul; 397(1):134-43. PubMed ID: 238630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Tisdale MJ; Phillips BJ
    Chem Biol Interact; 1977 Dec; 19(3):375-81. PubMed ID: 202413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Nov; 25(21):2365-70. PubMed ID: 187201
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies on cyclic AMP binding and protein kinase in cyclic AMP-responsive and -unresponsive Walker 256 mammary carcinomas.
    Cho-Chung YS; Clair T; Yi PN; Parkison C
    J Biol Chem; 1977 Sep; 252(18):6335-41. PubMed ID: 19471
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma.
    Cho-Chung YS; Newcomer SF
    Cancer Res; 1977 Dec; 37(12):4493-9. PubMed ID: 200352
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of protein kinases and phosphodiesterases in the cell cycle of Ph. polycephalum].
    Trakht NN; Grozdova ID; Severin ES; Gnuchev NV
    Biokhimiia; 1980 Apr; 45(4):636-43. PubMed ID: 6246974
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanisms of the cyclic AMP-dependent regulation of the enzymes of the 2',5'-oligoadenylate system.
    Itkes AV; Turpaev KT; Kartasheva ON; Tunitskaya VL; Kafiani CA
    FEBS Lett; 1984 Jun; 171(1):101-5. PubMed ID: 6327390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some biochemical properties of alkyl phosphotriesters of cyclic AMP.
    Gillen RG; Nagyvary J
    Biochem Biophys Res Commun; 1976 Feb; 68(3):836-40. PubMed ID: 177013
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase-a possible mechanism of action of bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):211-7. PubMed ID: 163094
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic AMP binding proteins and cyclic AMP-dependent protein kinase from Blastocladiella emersonii.
    Silverman PM
    J Bacteriol; 1978 Sep; 135(3):976-80. PubMed ID: 211118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth.
    Insel PA; Bourne HR; Coffino P; Tomkins GM
    Science; 1975 Nov; 190(4217):896-8. PubMed ID: 171770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenosine cyclic monophosphate level, adenyl cyclase activity, 3,5'-cyclic AMP phosphodiesterase and protein kinases in rat brain in experimental carbon monoxide poisoning].
    Sikorska M
    Neuropatol Pol; 1980; 18(2):203-17. PubMed ID: 6251408
    [No Abstract]   [Full Text] [Related]  

  • 17. Gonadotropin action in isolated ovarian luteal cells: the intermediate role of adenosine 3', 5' cyclic monophosphate in hormonal stimulation of progesterone synthesis.
    Sala GB; Dufau ML; Catt KJ
    Adv Exp Med Biol; 1979; 112():489-503. PubMed ID: 223396
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous opioids and cyclic AMP.
    Wollemann M
    Prog Neurobiol; 1981; 16(2):145-54. PubMed ID: 6269146
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and enzymatic activity of adenosine 3',5'-cyclic phosphate analogs.
    Marumoto R; Yoshioka Y; Naka T; Shima S; Miyashita O; Maki Y; Suzuki T; Honjo M
    Chem Pharm Bull (Tokyo); 1979 Apr; 27(3):990-1003. PubMed ID: 225047
    [No Abstract]   [Full Text] [Related]  

  • 20. Basal cAMP in Hela cells is protected from phosphodiesterase and does not turn over.
    Hilz H; Kaukel E; Wiegers U; Fuhrmann U
    Biochem Biophys Res Commun; 1975 May; 64(2):519-27. PubMed ID: 167746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.